These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26146463)

  • 21. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-17 as a drug target in human disease.
    Ivanov S; Lindén A
    Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The progress in clinical diagnosis and treatment for overlap syndrome of autoimmune liver diseases].
    Lin JS; Yu JL
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):332-4. PubMed ID: 20509995
    [No Abstract]   [Full Text] [Related]  

  • 25. The lymphoid liver: considerations on pathways to autoimmune injury.
    Kita H; Mackay IR; Van De Water J; Gershwin ME
    Gastroenterology; 2001 May; 120(6):1485-501. PubMed ID: 11313320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangiopathy.
    Peters MG
    Clin Liver Dis; 1998 May; 2(2):235-47, vii-viii. PubMed ID: 15560030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune liver disease, autoimmunity and liver transplantation.
    Carbone M; Neuberger JM
    J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune hepatitis and primary sclerosing cholangitis.
    Alvarez F
    Clin Liver Dis; 2006 Feb; 10(1):89-107, vi. PubMed ID: 16376796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Image analysis in autoimmune liver diseases].
    Zhang XL; Shi Y; Chen C
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):52. PubMed ID: 15670495
    [No Abstract]   [Full Text] [Related]  

  • 31. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.
    Silveira MG; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):329-40. PubMed ID: 19072425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
    Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric Autoimmune Liver Disease.
    Liberal R; Vergani D; Mieli-Vergani G
    Dig Dis; 2015; 33 Suppl 2():36-46. PubMed ID: 26641670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S99-108. PubMed ID: 11689782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of overlap syndromes.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of autoimmunity in patients with cholestatic liver diseases.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):73-91. PubMed ID: 26523975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia's Pacific Northwest.
    Yoshida EM; Riley M; Arbour LT
    World J Gastroenterol; 2006 Jun; 12(23):3625-7. PubMed ID: 16773676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting IL-23 in human diseases.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Targets; 2010 Jul; 14(7):759-74. PubMed ID: 20536413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting IL-17 in autoimmunity and inflammation.
    Kim BS; Park YJ; Chung Y
    Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.
    Lawson A; West J; Aithal GP; Logan RF
    Aliment Pharmacol Ther; 2005 Feb; 21(4):401-5. PubMed ID: 15709990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.